You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CRTh2

Showing 1 - 25 of 52
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Asthma, Rhinovirus, Picornaviridae Infections Trial in London (OC459, Placebo, Rhinovirus)

Completed
Has Results
  • Asthma
  • +3 more
  • London, Greater London, United Kingdom
    St Mary's Hospital
Feb 9, 2021

ADVATE 2 mL Post-Authorization Safety Surveillance (PASS)

Completed
  • Hemophilia A
  • Congenital Factor VIII (FVIII) Deficiency
  • Octocog alfa (recombinant human coagulation factor VIII) [ADVATE]
  • BORDEAUX Cedex, France
  • +16 more
Mar 15, 2021

ADVATE/ ADYNOVI Hemophilia A Outcome Database (AHEAD)

Active, not recruiting
  • Hemophilia A
  • ADVATE
  • ADYNOVI
  • Camperdown, New South Wales, Australia
  • +109 more
Apr 22, 2022

Type 1 Diabetes Trial in MIlan (Probiotic Vivomixx®, Placebo)

Recruiting
  • Type 1 Diabetes
  • Probiotic Vivomixx®
  • Placebo
  • MIlan, Italy
    Autoimmune Pathogenesis Unit
Mar 10, 2023

Allergic Rhinitis Trial in Changsha (TQC3564 tablets, Placebo tablets, TQC3564 tablets, montelukast sodium tablets)

Recruiting
  • Allergic Rhinitis
  • TQC3564 tablets
  • +3 more
  • Changsha, Hunan, China
    Xiangya Hospital Central South University
Nov 1, 2022

Viral Infection, Sepsis Trial in Limoges (Blood sample)

Not yet recruiting
  • Viral Infection
  • Sepsis
  • Blood sample
  • Limoges, France
    Limoges University Hospital
Jan 2, 2023

Allergy;Food, Allergy to Shrimp, Allergy to Cashew Nut (Disorder) Trial in Mountain View (Cashew or Shrimp Oral Immunotherapy)

Active, not recruiting
  • Allergy;Food
  • +2 more
  • Cashew or Shrimp Oral Immunotherapy
  • Mountain View, California
    Sean N Parker Center For Allergy and Asthma Research
May 26, 2022

Early Real-world Evidence of Brolucizumab in Neovascular

Completed
  • Neurovascular Age-related Macular Degeneration
    • Bangalore, India
    • +3 more
    Apr 26, 2023

    Russian Registry of Patients With nAMD

    Terminated
    • Neovascular Age-Related Macular Degeneration
    • nAMD
    • (no location specified)
    Jan 16, 2023

    Neovascular Age-related Macular Degeneration Trial in Italy (Brolucizumab)

    Recruiting
    • Neovascular Age-related Macular Degeneration
    • Ancona, AN, Italy
    • +18 more
    Aug 10, 2022

    Asthma Trial in Long Beach (HA115, Placebo)

    Withdrawn
    • Asthma
    • Long Beach, California
      CNS Network
    Sep 3, 2021

    Ocular Adverse Events in Neovascular Agerelated Macular

    Completed
    • Age-related Macular Degeneration (AMD)
    • Aflibercept
    • +2 more
    • East Hanover, New Jersey
      Novartis Investigative Site
    Dec 15, 2021

    Ocular Adverse Events in Neovascular Age-related Macular

    Completed
    • Age-related Macular Degeneration (AMD)
    • Aflibercept
    • +2 more
    • East Hanover, New Jersey
      Novartis Investigative Site
    Dec 15, 2021

    Neovascular Age-related Macular Degeneration Trial in Puerto Rico, United States (Brolucizumab 6 mg, Aflibercept 2 mg)

    Completed
    Has Results
    • Neovascular Age-related Macular Degeneration
    • Brolucizumab 6 mg
    • Aflibercept 2 mg
    • Peoria, Arizona
    • +64 more
    Dec 9, 2020

    Role of Eosinophil in Fibrogenesis of Systemic Sclerosis

    Unknown status
    • Systemic Sclerosis
    • Systemic Scleroderma
    • Blood test
    • Skin biopsies
    • Lille, France
      Hôpital Claude Huriez, CHU
    Mar 10, 2021

    Automated Optical Coherence Tomography Image Enrichment With

    Active, not recruiting
    • Neovascular Age-Related Macular Degeneration
    • Hamilton, Ontario, Canada
    • +16 more
    Aug 8, 2022

    Congenital Antithrombin Deficiency Trial in Worldwide (Atenativ)

    Recruiting
    • Congenital Antithrombin Deficiency
    • Washington, District of Columbia
    • +13 more
    Sep 16, 2022

    COPD Trial in Germany, United Kingdom (QAW039, Placebo)

    Terminated
    Has Results
    • Chronic Obstructive Pulmonary Disease
    • Frankfurt, Germany
    • +3 more
    Oct 7, 2021

    Severe Asthma Trial in Roma (anti IL5 receptor antibodies)

    Recruiting
    • Severe Asthma
    • anti IL5 receptor antibodies
    • Roma, Italy
      Campus Bio Medico University and Teaching Hospital
    Aug 5, 2021

    Evaluation of Eosinophil Phenotype in COPD Patients

    Recruiting
    • COPD
    • COPD Exacerbation
    • biomarker identification
    • Roma, RM, Italy
      IRCCS San Raffaele Pisana
    Feb 15, 2021

    Number of Patient Eyes That Remained on or Switched to Anti-VEGF

    Completed
    • Age-related Macular Degeneration (AMD)
    • East Hanover, New Jersey
      Novartis Investigational site
    Oct 6, 2021

    Patients Receiving Beovu in Neovascular Age-related Macular

    Recruiting
    • Neovascular Age-related Macular Degeneration (nAMD)
    • Luedenscheid, NRW, Germany
    • +48 more
    Sep 16, 2022

    Diabetic Macular Edema Trial in China (Brolucizumab, Aflibercept)

    Active, not recruiting
    • Diabetic Macular Edema
    • Guangzhou, Guangdong, China
    • +23 more
    Jan 20, 2023

    Neovascular Age-related Macular Degeneration

    Completed
    • Age-related Macular Degeneration (AMD)
    • East Hanover, New Jersey
      Novartis Pharmaceuticals
    Oct 19, 2021

    Patients With nAMD in UK Routine Clinical Practice

    Recruiting
    • Neovascular Age-related Macular Degeneration
    • brolucizumab
    • Peterborough, Cambridgeshire, United Kingdom
    • +12 more
    Jul 18, 2022